Peter M. Grob

4.0k total citations · 2 hit papers
38 papers, 3.1k citations indexed

About

Peter M. Grob is a scholar working on Infectious Diseases, Molecular Biology and Virology. According to data from OpenAlex, Peter M. Grob has authored 38 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 14 papers in Molecular Biology and 13 papers in Virology. Recurrent topics in Peter M. Grob's work include HIV/AIDS drug development and treatment (15 papers), HIV Research and Treatment (13 papers) and Glycosylation and Glycoproteins Research (4 papers). Peter M. Grob is often cited by papers focused on HIV/AIDS drug development and treatment (15 papers), HIV Research and Treatment (13 papers) and Glycosylation and Glycoproteins Research (4 papers). Peter M. Grob collaborates with scholars based in United States, Switzerland and Japan. Peter M. Grob's co-authors include Mark Bothwell, Laurie Churchill, Anne G. Graham, Alonzo H. Ross, Susan Pav, Christopher Pargellis, Liang Tong, Pier F. Cirillo, John R. Regan and Neil Moss and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Nucleic Acids Research.

In The Last Decade

Peter M. Grob

37 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study

2000 692 citations Gilbert Greub, Manuel Battegay et al. The Lancet profile →
Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site

2002 669 citations Christopher Pargellis, Liang Tong et al. Nature Structural Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter M. Grob United States	22	1.2k	776	666	542	517	38	3.1k
Marçal Pastor‐Anglada Spain	42	1.8k 1.5×	750 1.0×	529 0.8×	200 0.4×	132 0.3×	184	5.6k
Scott L. Harbeson United States	17	703 0.6×	232 0.3×	428 0.6×	61 0.1×	556 1.1×	28	1.7k
G. Romeo Italy	31	1.3k 1.1×	149 0.2×	267 0.4×	256 0.5×	56 0.1×	144	2.9k
Janet M. Leeds United States	29	1.3k 1.1×	174 0.2×	382 0.6×	245 0.5×	35 0.1×	72	2.9k
Nadya I. Tarasova United States	34	2.5k 2.1×	141 0.2×	230 0.3×	144 0.3×	65 0.1×	94	3.9k
Ruth F. Nutt United States	28	1.8k 1.5×	234 0.3×	271 0.4×	201 0.4×	32 0.1×	59	3.0k
Lei Jin United States	33	2.7k 2.3×	142 0.2×	377 0.6×	56 0.1×	54 0.1×	53	4.2k
Sylvia Y.M. Yao Canada	31	1.4k 1.2×	640 0.8×	436 0.7×	111 0.2×	34 0.1×	61	4.3k
Steven G. Nadler United States	38	1.5k 1.3×	153 0.2×	237 0.4×	128 0.2×	98 0.2×	87	3.8k
Thomas P. Zimmerman United States	26	1.1k 0.9×	458 0.6×	518 0.8×	205 0.4×	31 0.1×	68	2.1k

Countries citing papers authored by Peter M. Grob

Since Specialization

Citations

This map shows the geographic impact of Peter M. Grob's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter M. Grob with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter M. Grob more than expected).

Fields of papers citing papers by Peter M. Grob

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter M. Grob. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter M. Grob. The network helps show where Peter M. Grob may publish in the future.

Co-authorship network of co-authors of Peter M. Grob

This figure shows the co-authorship network connecting the top 25 collaborators of Peter M. Grob. A scholar is included among the top collaborators of Peter M. Grob based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter M. Grob. Peter M. Grob is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Tong, Christopher Pargellis, Laurie Churchill, et al.. (2002). Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site. Acta Crystallographica Section A Foundations of Crystallography. 58(s1). c231–c231. 7 indexed citations

Pargellis, Christopher, Liang Tong, Laurie Churchill, et al.. (2002). Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site. Nature Structural Biology. 9(4). 268–272. 669 indexed citations breakdown →

Greub, Gilbert, Manuel Battegay, Peter M. Grob, et al.. (2000). Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. The Lancet. 356(9244). 1800–1805. 692 indexed citations breakdown →

Grob, Peter M.. (1998). Report on Working Group 2: Austria, Belgium, Bulgaria, Germany, Greece, Hungary, Malta, Russia, Switzerland, Turkey and Uzbekistan. Vaccine. 16. S61–S62. 7 indexed citations

Grob, Peter M.. (1998). Hepatitis B: virus, pathogenesis and treatment. Vaccine. 16. S11–S16. 12 indexed citations

Grob, Peter M., Yunzhen Cao, Elizabeth Muchmore, et al.. (1997). Prophylaxis against HIV-1 infection in chimpanzees by nevirapine, a nonnucleoside inhibitor of reverse transcriptase. Nature Medicine. 3(6). 665–670. 28 indexed citations

Miao, Clara K., Charles L. Cywin, Ronald Sorcek, et al.. (1997). Effect of Structural Modification of Enol−Carboxamide-Type Nonsteroidal Antiinflammatory Drugs on COX-2/COX-1 Selectivity. Journal of Medicinal Chemistry. 40(6). 980–989. 74 indexed citations

Kelly, Tracy, John Proudfoot, Daniel W. McNeil, et al.. (1995). Novel Non-nucleoside Inhibitors of Human Immunodeficiency Virus Type 1 Reverse Transcriptase. 5. 4-Substituted and 2,4-Disubstituted Analogs of Nevirapine. Journal of Medicinal Chemistry. 38(24). 4839–4847. 32 indexed citations

Meštrović, Tomislav, Martin Tönz, Ludwig K. von Segesser, et al.. (1995). The influence of leukocyte filtration during cardiopulmonary bypass on postoperative lung function: A clinical study. Journal of Thoracic and Cardiovascular Surgery. 109(6). 1138–1145. 70 indexed citations

10.

Kossmann, Thomas, Volkmar Hans, Hans-Georg Imhof, et al.. (1995). INTRATHECAL AND SERUM INTERLEUKIN-6 AND THE ACUTE-PHASE RESPONSE IN PATIENTS WITH SEVERE TRAUMATIC BRAIN INJURIES. Shock. 4(5). 311–317. 229 indexed citations

11.

Gliński, Jan A., Eva David, Thomas C. Warren, et al.. (1995). INACTIVATION OF CELL SURFACE RECEPTORS BY PHEOPHORBIDE a, A GREEN PIGMENT ISOLATED FROM Psychotria acuminata. Photochemistry and Photobiology. 62(1). 144–150. 26 indexed citations

12.

Grob, Peter M.. (1995). Introduction to epidemiology and risk of hepatitis B. Vaccine. 13. S14–S15. 7 indexed citations

13.

Hopkins, Jerry L., Richard H. Ingraham, Thomas C. Warren, et al.. (1994). High-performance liquid chromatography and photoaffinity crosslinking to explore the binding environment of nevirapine to reverse transcriptase of human immunodeficiency virus type-1. Journal of Chromatography A. 676(1). 99–112. 8 indexed citations

14.

Koup, Richard A., Frank Brewster, Peter M. Grob, & John L. Sullivan. (1993). Nevirapine synergistically inhibits HIV-1 replication in combination with zidovudine, interferon or CD4 immunoadhesin. AIDS. 7(9). 1181–1184. 20 indexed citations

15.

Grob, Peter M., Joseph C. Wu, K.A. Cohen, et al.. (1992). Nonnucleoside Inhibitors of HIV-1 Reverse Transcriptase: Nevirapine as a Prototype Drug. AIDS Research and Human Retroviruses. 8(2). 145–152. 73 indexed citations

16.

Wu, Joseph C., Thomas C. Warren, Julian Adams, et al.. (1991). A novel, dipyridodiazepinone inhibitor of HIV-1 reverse transcriptase acts through a nonsubstrate binding site. Biochemistry. 30(8). 2022–2026. 158 indexed citations

17.

Kopp, Elizabeth B., et al.. (1991). Steady state kinetics and inhibition of HIV-1 reverse transcriptase by a non-nucleoside dipyridodiazepinone, BI-RG-587, using a heteropolymeric template. Nucleic Acids Research. 19(11). 3035–3039. 47 indexed citations

18.

Grob, Peter M., Catherine H. Berlot, & Mark Bothwell. (1983). Affinity labeling and partial purification of nerve growth factor receptors from rat pheochromocytoma and human melanoma cells.. Proceedings of the National Academy of Sciences. 80(22). 6819–6823. 85 indexed citations

19.

Grob, Peter M. & Mark Bothwell. (1983). Modification of nerve growth factor receptor properties by wheat germ agglutinin.. Journal of Biological Chemistry. 258(23). 14136–14143. 37 indexed citations

20.

Grob, Peter M. & Kailash C. Chadha. (1979). Separation of human leukocyte interferon components by concanavalin A-agarose affinity chromatography and their characterization. Biochemistry. 18(26). 5782–5786. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact